94 related articles for article (PubMed ID: 455286)
21. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
Schafer R; Nacy CA; Eisenstein TK
J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
[TBL] [Abstract][Full Text] [Related]
22. Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin.
Mace K; Mayhew E; Mihich E; Ehrke MJ
Cancer Res; 1988 Jan; 48(1):130-6. PubMed ID: 3257160
[TBL] [Abstract][Full Text] [Related]
23. Response of murine leukemia to combined BCNU-maleic anhydride-vinyl ether (MVE) adjuvant therapy and correlation with macrophage activation by MVE in the in vitro growth inhibition assay.
Dean JH; Padarathsingh ML; Keys L
Cancer Treat Rep; 1978 Nov; 62(11):1807-16. PubMed ID: 728898
[No Abstract] [Full Text] [Related]
24. [Induction of the tumoricidal activity of human and murine peritoneal macrophages under the action of antitumor chemical preparations].
Potapov SL; Viadro MM
Biull Eksp Biol Med; 1989 Sep; 108(9):330-2. PubMed ID: 2611394
[TBL] [Abstract][Full Text] [Related]
25. Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity.
Fisher B; Wolmark N
Cancer Res; 1976 Jul; 36(7 PT 1):2241-7. PubMed ID: 1277129
[TBL] [Abstract][Full Text] [Related]
26. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells.
Morikawa K; Takeda R; Yamazaki M; Mizuno D
Cancer Res; 1985 Apr; 45(4):1496-501. PubMed ID: 3156669
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA
Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer.
Soloway MS
Natl Cancer Inst Monogr; 1978 Dec; (49):327-32. PubMed ID: 748788
[TBL] [Abstract][Full Text] [Related]
29. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
Schorlemmer HU; Bosslet K; Sedlacek HH
Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
[TBL] [Abstract][Full Text] [Related]
30. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
31. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
32. Combined effect of cytostatic drugs and E-N-L-trimethyl lysine in healthy and transplantable tumor bearing mice.
Szende B; Lapis K; Simon K
Neoplasma; 1982; 29(4):427-39. PubMed ID: 6813749
[TBL] [Abstract][Full Text] [Related]
33. Multiple tumoricidal effector mechanisms induced by adriamycin.
Salazar D; Cohen SA
Cancer Res; 1984 Jun; 44(6):2561-6. PubMed ID: 6327018
[TBL] [Abstract][Full Text] [Related]
34. Generation of anti-MOPC-315 cytotoxicity in uneducated or in vitro educated spleen cells from normal or MOPC-315 tumor-bearing mice pretreated in vivo with Bacillus Calmette-Guérin.
Braun DP; Mokyr MB; Dray S
Cancer Res; 1978 Jun; 38(6):1626-32. PubMed ID: 647676
[TBL] [Abstract][Full Text] [Related]
35. Hyperthermic modulation of respiratory inhibition factor- and iron releasing factor-dependent macrophage murine tumor cytotoxicity.
Klostergaard J; Barta M; Tomasovic SP
Cancer Res; 1989 Nov; 49(22):6252-7. PubMed ID: 2680061
[TBL] [Abstract][Full Text] [Related]
36. Acceleration of myeloid recovery from cyclophosphamide-induced leukopenia by pretreatment with Bacillus Calmette-Guérin.
Ladisch S; Poplack DG; Bull JM
Cancer Res; 1978 Apr; 38(4):1049-51. PubMed ID: 639036
[TBL] [Abstract][Full Text] [Related]
37. Chemical and biological adjuvants capable of potentiating tumor cell vaccine.
Chirigos MA; Stylos WA; Schultz RM; Fullen JR
Cancer Res; 1978 Apr; 38(4):1085-91. PubMed ID: 416906
[TBL] [Abstract][Full Text] [Related]
38. Effect of chemotherapeutic agents on natural and BCG-stimulated macrophage cytotoxicity in mice.
Mantovani A; Luini W; Candiani GP; Spreafico F
Int J Immunopharmacol; 1980; 2(4):333-9. PubMed ID: 7009446
[TBL] [Abstract][Full Text] [Related]
39. Endogenous production of cytotoxic factors in serum of BCG-primed mice by monophosphoryl lipid A, a detoxified form of endotoxin.
Bennett JA; Peters JH; Chudacoff R; McKneally MF
J Biol Response Mod; 1988 Feb; 7(1):65-76. PubMed ID: 3373236
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity to chemotherapeutic and immunomodulating agents of two mouse lymphomas and of a macrophage tumor.
Tarnowski GS; Ralph P; Stock CC
Cancer Res; 1979 Oct; 39(10):3964-7. PubMed ID: 476634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
